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C arcinoma of the esophagus and esophagogastricjunction is a lethal disease. Our ability to cure this
cancer is limited because most patients have dysphagia
and advanced stage disease when first evaluated. A
symptomatic tumor that obstructs the esophageal lumen
has usually spread beyond the esophageal musculature
to involve the periesophageal tissue and/or adjacent
organs and has metastasized to regional lymph nodes
and/or distant sites.
The recent shift in epidemiology of esophageal carci-
noma provides an opportunity for improved survival.
This epidemic of adenocarcinoma in middle-aged and
elderly white men permits screening of a high-risk
group, which can identify patients with carcinomas
confined to the esophageal wall. However, a carcinoma
confined to the esophageal wall is not necessarily a car-
cinoma that has not metastasized.
Lymphatic drainage of the esophagus allows for early
dissemination of carcinoma in many patients before
symptoms develop (Fig 1). The presence of lymphatics
in the lamina propria and muscularis mucosa deep to
the basement membrane makes the esophagus unique
among gastrointestinal hollow viscus organs. These
lymphatics drain into the rich submucosal lymphatic
plexus and spread longitudinally through this dense
lymphatic network. Lymphatics intermittently pierce
the muscularis propria to drain into regional lymph
nodes or directly into the thoracic duct. This anatomic
peculiarity exposes lymphatics to carcinoma at the ear-
liest stage of invasion, just after the carcinoma breach-
es the basement membrane and invades the lamina pro-
pria (Fig 2). As tumors invade deeper into the wall,
there is rapid, extensive spread in the submucosal lym-
phatic network and an increasing prevalence of regional
lymph node metastases.1
Nigro and colleagues2 report a prevalence of lymph
node metastases that increases with increasing depth of
tumor invasion. The prevalence of regional lymph node
COMMENTARY: ESOPHAGEAL CARCINOMA CONFINED TO THE WALL—THE NEED FOR IMMEDIATE
DEFINITIVE THERAPY
Thomas W. Rice, MD
From the Department of Thoracic and Cardiovascular Surgery, The
Cleveland Clinic Foundation, Cleveland, Ohio.
Requested for publication Aug 5, 1998; received Sept 21, 1998;
accepted for publication Oct 1, 1998.
Address for reprints: Thomas W. Rice, MD, Head of the Section of
General Thoracic Surgery, The Cleveland Clinic Foundation,
9500 Euclid Ave, Cleveland, OH 44195.
J Thorac Cardiovasc Surg 1999;117:26-7
Copyright © 1999 by Mosby, Inc.
0022-5223/99 $8.00 + 0 12/6/94980
Fig 1. The lymphatic anatomy of the esophagus. Lymphatics are found in the lamina propria just below the base-
ment membrane. An intramucosal tumor is seen with invasion of the lamina propria.
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metastases (N1) was 7% for T1 tumors with invasion
confined to the esophageal mucosa (lamina propria or
muscularis mucosa), 50% for T1 tumors with submu-
cosal invasion, and 80% for T2 tumors. Distant nodal
metastases (M1a) were detected in 14% (1/7) of
patients with T1 carcinomas and 63% (5/8) of patients
with T2 tumors. These findings are consistent with the
lymphatic anatomy of the esophagus where deeper
invasion is associated with increasing lymphatic expo-
sure and therefore an escalating potential for both
regional and distant lymph node metastases.
Cure is possible only if a carcinoma is contained in
the treatment field. In patients with high-grade dyspla-
sia (intraepithelial carcinoma), there is no chance for
lymphatic spread because the malignant tumor is limit-
ed by the basement membrane.1,3,4 The potential of
cure decreases exponentially with increasing invasion
of the esophageal wall.
Mucosal ablative treatments (photodynamic therapy)
are dangerous. These experimental therapies incom-
pletely destroy the superficial layers of the esophageal
wall and do not penetrate to eradicate deeper invasion or
submucosal lymphatic spread. The dysplastic or invasive
changes may be submerged below the pseudosquamous
epithelium, thus hiding these changes from surveillance.
Most importantly, curative treatment is delayed, allow-
ing deeper invasion and lymphatic metastases.
Diligent surveillance of high-risk groups identifies
patients with preinvasive or early invasive carcinomas.
Excision before lymphatic invasion is the only hope for
improved survival.
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Fig 2. Photomicrograph of intramucosal adenocarcinoma of
the columnar-lined esophagus with invasion of the lymphatic
in the lamina propria (arrows).
